Skip to main content

Advertisement

SpringerLink
Log in

Expression Cloning of cDNAs That Render Cancer Cells Resistant to Pseudomonas and Diphtheria Toxin and Immunotoxins

  • Original Articles
  • Published:
Molecular Medicine Aims and scope Submit manuscript

Abstract

Background

Several immunotoxins in which antibodies are coupled to plant or bacterial toxins are now in clinical trials for the treatment of cancer. One of these is B3-LysPE38 in which MAb B3 which reacts with many human cancers, is coupled with a genetically modified form of Pseudomonas exotoxin (PE).

Materials and Methods

To investigate how cells can become resistant to PE-derived immunotoxins, we constructed an immunotoxin-sensitive MCF-7 breast cancer cell line that contains SV40 T antigen and allows episomal replication of SV40 origin containing Plasmids. We transfected a pCDM8/HeLa cDNA expression library into these cells, thereby causing over-expression of the plasmid-encoded genes. The transfected cells were treated with immunotoxin to select for resistance-mediating plasmids, which were reisolated from these cells and amplified in Escherichia coli. The resulting plasmid pool was transfected into cells for two further rounds of selection and plasmid reisolation.

Results

Several plasmids that caused immunotoxin resistance were enriched by this selection procedure. Four plasmids were stably transfected into MCF-7 cells and found to increase their resistance to PE-derived immunotoxins by 5- to 20-fold. These plasmids also confer resistance to native PE and to diphtheria toxin but not to ricin or cycloheximide. Thus, they appear to specifically interfere with the action of ADP-ribosylating toxins.

Conclusion

Cancer cells can become resistant to immunotoxins by deregulated expression of normal genes. The clinical significance of this type of resistance will be evaluated in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Vitetta ES, Thorpe PE, Uhr JW. (1993) Immunotoxins: Magic bullets or misguided missiles? Trends Pharmacol. Sci. 14: 148–154.

    Article  CAS  PubMed  Google Scholar 

  2. Pastan I, Chaudhary VK, FitzGerald DJ. (1992) Recombinant toxins as novel therapeutic agents. Annu. Rev. Biochem. 61: 331–354.

    Article  CAS  PubMed  Google Scholar 

  3. Vitetta ES. (1994) From the basic science of B cells to biological missiles at the bedside. J. Immunol. 153: 1407–1420.

    PubMed  CAS  Google Scholar 

  4. Pastan I, Pai LH, Brinkmann U, FitzGerald DJ. (in press) Recombinant toxins: New therapeutic agents for cancer. Ann. N.Y. Acad. Sci.

  5. Brinkmann U, Pastan I. (1994) Immunotoxins against cancer. Biochem. Biophys. Acta. 1198: 27–45.

    PubMed  CAS  Google Scholar 

  6. Kondo T, FitzGerald D, Chaudhary VK, Adhya S, Pastan I. (1988) Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. J. Biol. Chem. 263: 9470–9475.

    PubMed  CAS  Google Scholar 

  7. Pastan I, Lovelace ET, Gallo MG, Rutherford AV, Magnani JL, Willingham MC. (1991) Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res. 51: 3781–3787.

    PubMed  CAS  Google Scholar 

  8. Pai LH, FitzGerald DJ, Willingham MC, Pastan I. (1991) Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin. Proc. Natl. Acad. Sci. U.S.A. 88: 3358–3362.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Brinkmann U, Pai LH, FitzGerald DJ, Pastan I. (1991) B3(Fv)-PE38KDEL, a single chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. U.S.A. 88: 8616–8620.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Moehring JM, Inocencio NM, Robertson BJ, Moehring TJ. (1993) Expression of mouse furin in a Chinese hamster cell resistant to Pseudomonas exotoxin A and viruses complements the genetic lesion. J. Biol. Chem. 268: 2590–2594.

    PubMed  CAS  Google Scholar 

  11. Laurie SM, Robbins AR. (1991) A toxin-resistant mouse L-cell mutant defective in protein transport along the secretory pathway. J. Cell Physiol. 147: 215–223.

    Article  CAS  PubMed  Google Scholar 

  12. Kimata Y, Kohno K. (1994) Elongation factor 2 mutants deficient in diphthamide formation show temperature-sensitive cell growth. J. Biol. Chem. 269: 13497–13501.

    PubMed  CAS  Google Scholar 

  13. Kido M, Miwatani H, Kohno K, Uchida T, Okada Y. (1991) Targeted introduction of a diphtheria toxin-resistant point mutation into the chromosomal EF-2 locus by in vivo homologous recombination. Cell Struct. Fund. 16: 447–453.

    Article  CAS  Google Scholar 

  14. Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ. (1992) Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells. Eur. J. Biochem. 205: 25–31.

    Article  CAS  PubMed  Google Scholar 

  15. Chaudhary VK, Jinno Y, FitzGerald D, Pastan I. (1990) Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 87: 308–312.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zdanovsky AG, Chiron M, Pastan I, FitzGerald DJ. (1993) Mechanism of action of Pseudomonas exotoxin: Identification of a rate-limiting step. J. Biol. Chem. 29: 21791–2179.

    Google Scholar 

  17. Goldstein LJ, Galski H, Fojo A, et al. (1989) Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81: 116–124.

    Article  CAS  PubMed  Google Scholar 

  18. Endicott JA, Ling V. (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58: 137–171.

    Article  CAS  PubMed  Google Scholar 

  19. Gottesman MM, Pastan I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385–427.

    Article  CAS  PubMed  Google Scholar 

  20. Schimke RT. (1984) Gene amplification in cultured animal cells. Cell 37: 705–713.

    Article  CAS  PubMed  Google Scholar 

  21. Schimke RT. (1988) Gene amplification in cultured cells. J. Biol. Chem. 263: 5989–5992.

    PubMed  CAS  Google Scholar 

  22. Buchner J, Pastan I, Brinkmann U. (1992) A method to increase the yield of properly folded recombinant fusion proteins: E.g., single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205: 263–270.

    Article  CAS  PubMed  Google Scholar 

  23. Ogryzko VV, Hirai TH, Shih CE, Howard BH. (1994) Dissociation of retinoblastoma gene protein hyperphosphorylation and commitment to enter S phase. J. Virol. 68: 3724–3732.

    PubMed  PubMed Central  CAS  Google Scholar 

  24. Maniatis T, Sambrook J, Frisch EF. (1989) Molecular cloning. A Laboratory Manual. 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

    Google Scholar 

  25. Hirt B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26: 365–369.

    Article  CAS  PubMed  Google Scholar 

  26. Martin R, Hoover C, Grimme S, Grogan C, Holtke J, Kessler, C. (1990) A highly sensitive, nonradioactive DNA labeling and detection system. BioTechniques 9: 762–768.

    PubMed  CAS  Google Scholar 

  27. Cory AH, Owen TC, Barltrop JA, Cory JG. (1991) Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3: 207–212.

    Article  CAS  PubMed  Google Scholar 

  28. Brinkmann U, Reiter Y, Jung S-H, Lee B, Pastan I. (1993) A recombinant immunotoxin containing a disulfide-stabilized Fv fragment (dsFv). Proc. Natl. Acad. Sci. U.S.A. 90: 7538–7542.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Okayama H, Berg P. (1982) High-efficiency cloning of full-length cDNA. Mol. Cell. Biol. 2: 161–170.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Suter W, Negro L, Barrera I, Schneider B. (1992) Resistance to Pseudomonas exotoxin A: A sensitive marker to screen for mutagenic substances using V79 cells. Mutagenesis 7: 125–135.

    Article  CAS  PubMed  Google Scholar 

  31. Tiah M, Ronen A. (1991) Dominant lethal cell mutants detected by the autoradiographic assay for exotoxin A resistance. Mutat. Res. 249: 211–222.

    Article  CAS  PubMed  Google Scholar 

  32. Hwang J, Richert N, Pastan I, Gottesman MM. (1987) Mutant KB cells with decreased EGF receptor expression: Biochemical characterization. J. Cell. Physiol. 133: 127–134.

    Article  CAS  PubMed  Google Scholar 

  33. Lyall RM, Hwang J, Cardarelli C, et al. (1987) Isolation of human KB cell lines resistant to epidermal growth factor-Pseudomonas exotoxin conjugates. Cancer Res. 47: 2961–2966.

    PubMed  CAS  Google Scholar 

  34. Gudkov AV, Kazarov AR, Thimmapaya R, Axenovich SA, Mazo LA, Roninson IB. (1994) Cloning mammalian genes by expression selection of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization. Proc. Natl. Acad. Sci. U.S.A. 91: 3744–3748.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gudkov AV, Zelnick CR, Kazarov AR, et al. (1993) Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc. Natl. Acad. Sci. U.S.A. 90: 3231–3235.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Kruh GD, Chan A, Myers K, Gaughan K, Miki T, Aaronson SA. (1994) Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res. 54: 1649–1652.

    PubMed  CAS  Google Scholar 

  37. Chan AM, Miki T, Meyers KA, Aaronson SA. (1994) A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. Proc. Natl. Acad. Sci. U.S.A. 91: 7558–7562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Biology, Division of Cancer Biology, Diagnosis, and Centers, National Cancer Institute, National Institutes of Health, Building 37, Room 4E16, 37 CONVENT DR MSC 4255, Bethesda, MD, 20892-4255, USA

    Ulrich Brinkmann & Ira Pastan

  2. Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, Bethesda, Maryland, USA

    Elisabeth Brinkmann

Authors
  1. Ulrich Brinkmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabeth Brinkmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ira Pastan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brinkmann, U., Brinkmann, E. & Pastan, I. Expression Cloning of cDNAs That Render Cancer Cells Resistant to Pseudomonas and Diphtheria Toxin and Immunotoxins. Mol Med 1, 206–216 (1995). https://doi.org/10.1007/BF03401568

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401568

Search

Navigation